We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sandoz Kicks Off Supreme Court Biosimilar Battle

Law360, New York (February 10, 2017, 8:06 PM EST) -- The Federal Circuit erred by forcing biosimilar makers to win approval before supplying 180-day notice of sales to rivals, Sandoz told the U.S. Supreme Court on Friday, kicking off a showdown...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.